| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.0006 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |